{
    "2018-09-14": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Noteworthy ETF Outflows: MTUM, ABBV, ISRG, SPGI",
                "features": {
                    "keywords": [
                        "ETF",
                        "Outflows",
                        "MTUM",
                        "ABBV",
                        "ISRG",
                        "SPGI"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-03",
                "original_text": "Roche's Child Arthritis Drug's New Formulation Gets FDA Nod",
                "features": {
                    "keywords": [
                        "Roche",
                        "Child Arthritis",
                        "Drug",
                        "FDA",
                        "Nod"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-04",
                "original_text": "Pharma/Biotech Stocks to Watch This Prostate Cancer Month",
                "features": {
                    "keywords": [
                        "Pharma",
                        "Biotech",
                        "Stocks",
                        "Prostate Cancer"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-05",
                "original_text": "Top Stock Reports for JPMorgan, Mastercard & AbbVie",
                "features": {
                    "keywords": [
                        "Stock Reports",
                        "JPMorgan",
                        "Mastercard",
                        "AbbVie"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance",
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-06",
                "original_text": "3 Things You Might Be Overlooking With AbbVie",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Overlooking"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-07",
                "original_text": "Roche's Child Arthritis Drug's New Formulation Gets FDA Nod",
                "features": {
                    "keywords": [
                        "Roche",
                        "Child Arthritis",
                        "Drug",
                        "FDA",
                        "Nod"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-08",
                "original_text": "Neurocrine Biosciences: Analysts Are Mostly Positive",
                "features": {
                    "keywords": [
                        "Neurocrine Biosciences",
                        "Analysts",
                        "Positive"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-09",
                "original_text": "Todayâ€™s Research Reports on Stocks to Watch: AbbVie and Progenics Pharmaceuticals",
                "features": {
                    "keywords": [
                        "Research Reports",
                        "Stocks",
                        "AbbVie",
                        "Progenics Pharmaceuticals"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-10",
                "original_text": "A Brawl Is Brewing Between AbbVie and Gilead Sciences in Arthritis",
                "features": {
                    "keywords": [
                        "Brawl",
                        "AbbVie",
                        "Gilead Sciences",
                        "Arthritis"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-11",
                "original_text": "Johnson & Johnson Expands Blood Cancer Portfolio with Approval",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Blood Cancer",
                        "Portfolio",
                        "Approval"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}